Takeda Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -8.15% vs 7.09% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -455.15% vs 984.41% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,094,541.00",
          "val2": "1,191,698.00",
          "chgp": "-8.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "322,456.00",
          "val2": "381,261.00",
          "chgp": "-15.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "43,649.00",
          "val2": "123,627.00",
          "chgp": "-64.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-111,902.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-368,408.00",
          "val2": "103,733.00",
          "chgp": "-455.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "144.90%",
          "val2": "160.00%",
          "chgp": "-1.51%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -1.66% vs 7.45% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -240.67% vs -25.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,505,720.00",
          "val2": "4,581,551.00",
          "chgp": "-1.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,354,744.00",
          "val2": "1,388,939.00",
          "chgp": "-2.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "173,887.00",
          "val2": "186,976.00",
          "chgp": "-7.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-448,642.00",
          "val2": "-220,252.00",
          "chgp": "-103.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-152,125.00",
          "val2": "108,143.00",
          "chgp": "-240.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "140.60%",
          "val2": "137.00%",
          "chgp": "0.36%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1,094,541.00

1,191,698.00

-8.15%

Operating Profit (PBDIT) excl Other Income

322,456.00

381,261.00

-15.42%

Interest

43,649.00

123,627.00

-64.69%

Exceptional Items

-111,902.00

0.00

Consolidate Net Profit

-368,408.00

103,733.00

-455.15%

Operating Profit Margin (Excl OI)

144.90%

160.00%

-1.51%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -8.15% vs 7.09% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -455.15% vs 984.41% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

4,505,720.00

4,581,551.00

-1.66%

Operating Profit (PBDIT) excl Other Income

1,354,744.00

1,388,939.00

-2.46%

Interest

173,887.00

186,976.00

-7.00%

Exceptional Items

-448,642.00

-220,252.00

-103.69%

Consolidate Net Profit

-152,125.00

108,143.00

-240.67%

Operating Profit Margin (Excl OI)

140.60%

137.00%

0.36%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is -1.66% vs 7.45% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -240.67% vs -25.00% in Mar 2025

All Annual Results